Higher Art Adherence is Associated with Lower Systemic Inflammation in Treatment-Naïve Ugandans Who Achieve Virologic Suppression
Authors
Castillo-Mancilla, JRMorrow, M
Boum, Y
Byakwaga, H
Haberer, JE
Martin, JN
Bangsberg, D
Mawhinney, S
Musinguzi, N
Huang, Y
Tracy, RP
Burdo, TH
Williams, K
Muzoora, C
Hunt, PW
Siedner, MJ
Issue Date
2018-01-16Submitted date
2018-01-25
Metadata
Show full item recordAbstract
Residual systemic inflammation persists despite suppressive antiretroviral therapy (ART) and is associated with non-AIDS clinical outcomes. We aimed to evaluate the association between ART adherence and inflammation in Ugandans living with HIV who were predominantly receiving nevirapine-based ART with a thymidine analog backbone and were virologically suppressed by conventional assays.PubMed ID
29346185Language
enDescription
We regret that this article is behind a paywall.ISSN
1944-7884ae974a485f413a2113503eed53cd6c53
10.1097/QAI.0000000000001629
Scopus Count
Collections
Related articles
- Brief Report: Changes in Levels of Inflammation After Antiretroviral Treatment During Early HIV Infection in AIDS Clinical Trials Group Study A5217.
- Authors: Macatangay BJ, Yang M, Sun X, Morton J, De Gruttola V, Little S, Hogan C, Rinaldo CR, A5217 Team.
- Issue date: 2017 May 1
- Antiretroviral Therapy Adherence Interruptions Are Associated With Systemic Inflammation Among Ugandans Who Achieved Viral Suppression.
- Authors: Musinguzi N, Castillo-Mancilla J, Morrow M, Byakwaga H, Mawhinney S, Burdo TH, Boum Y, Muzoora C, Bwana BM, Siedner MJ, Martin JN, Hunt PW, Bangsberg DR, Haberer JE
- Issue date: 2019 Dec 1
- Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study.
- Authors: Castillo-Mancilla JR, Phillips AN, Neaton JD, Neuhaus J, Sharma S, Baker JV, Collins S, Mannheimer S, Pett S, Touzeau-Römer V, Polizzotto MN, Lundgren JD, Gardner EM, INSIGHT START Study Group.
- Issue date: 2019 Jun
- Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy.
- Authors: Lee S, Byakwaga H, Boum Y, Burdo TH, Williams KC, Lederman MM, Huang Y, Tracy RP, Cao H, Haberer JE, Kembabazi A, Bangsberg DR, Martin JN, Hunt PW
- Issue date: 2017 Apr 15
- Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy.
- Authors: Prendergast AJ, Szubert AJ, Berejena C, Pimundu G, Pala P, Shonhai A, Musiime V, Bwakura-Dangarembizi M, Poulsom H, Hunter P, Musoke P, Kihembo M, Munderi P, Gibb DM, Spyer M, Walker AS, Klein N, ARROW Trial Team.
- Issue date: 2016 Jul 15